Skip to main content
Daniel Troy, MD, Orthopaedic Surgery, Oak Lawn, IL, Northwestern Medicine Palos Hospital

DanielAnthonyTroyMD

Orthopaedic Surgery • Oak Lawn, IL

Orthopedic Spine Surgery, Orthopedic Sports Medicine

Physician

Join to view full profile

Are you Dr. Troy?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 71 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Daniel Troy, MD is a board certified orthopedic surgeon in Oak Lawn, Illinois. He is currently licensed to practice medicine in Illinois, Kentucky, and Georgia. He is affiliated with Advocate Christ Medical Center, Northwestern Medicine Palos Hospital, and OSF Healthcare Little Company of Mary Medical Center.

Education & Training

  • University of Illinois College of Medicine at Chicago
    University of Illinois College of Medicine at ChicagoResidency, Orthopaedic Surgery, 1995 - 2000
  • Rush Medical College of Rush University Medical Center
    Rush Medical College of Rush University Medical CenterClass of 1995

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 1995 - 2026
  • IN State Medical License
    IN State Medical License 1997 - 2007
  • KY State Medical License
    KY State Medical License 2002 - 2004
  • AL State Medical License
    AL State Medical License Active through 2001
  • GA State Medical License
    GA State Medical License 2000 - 2001
  • American Board of Orthopaedic Surgery Orthopaedic Surgery
  • American Board of Orthopaedic Surgery Orthopaedic Sports Medicine

Press Mentions

  • Neurorx, Inc. And Big Rock Partners Acquisition Corp. Announce Committed $10 Million Pipe to Support Proposed Business Combination
    Neurorx, Inc. And Big Rock Partners Acquisition Corp. Announce Committed $10 Million Pipe to Support Proposed Business CombinationMarch 15th, 2021
  • NeuroRx Initiates Phase 2/3 Study of Inhaled ZYESAMI™ for Severe COVID-19 with UCI Health
    NeuroRx Initiates Phase 2/3 Study of Inhaled ZYESAMI™ for Severe COVID-19 with UCI HealthFebruary 3rd, 2021
  • CORRECTION: NeuroRx and Relief Announce Initial Successful Results from Expanded Access Use of RLF-100(TM) (Aviptadil) in Patients with Critical COVID-19 and Severe Comorbidity: 72% Survival Seen in ICU Patients
    CORRECTION: NeuroRx and Relief Announce Initial Successful Results from Expanded Access Use of RLF-100(TM) (Aviptadil) in Patients with Critical COVID-19 and Severe Comorbidity: 72% Survival Seen in ICU PatientsNovember 25th, 2020
  • Join now to see all

Hospital Affiliations

Dr. Daniel Troy, Dr. Daniel Troy, MD, Dr. D Troy, Dr. Daniel Anthony Troy